Risk Factors for Bleeding and Clinical Ineffectiveness Associated With Clopidogrel Therapy: A Comprehensive Meta‐Analysis
Although clopidogrel is a frequently used antiplatelet medication to treat and prevent atherothrombotic disease, clinicians must balance its clinical effectiveness with the potential side effect of bleeding. However, many previous studies have evaluated beneficial and adverse factors separately. The...
Saved in:
Main Authors: | Khoa A. Nguyen (Author), Michael T. Eadon (Author), Ryan Yoo (Author), Evan Milway (Author), Allison Kenneally (Author), Kevin Fekete (Author), Hyun Oh (Author), Khanh Duong (Author), Elizabeth C. Whipple (Author), Titus K. Schleyer (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding
by: Paolo Nardi, et al.
Published: (2020) -
Effect of Co-Administration of Rivaroxaban and Clopidogrel on Bleeding Time, Pharmacodynamics and Pharmacokinetics: A Phase I Study
by: Michael Becka, et al.
Published: (2012) -
Immunomodulators in warts: Unexplored or ineffective?
by: Surabhi Sinha, et al.
Published: (2015) -
Management of Ineffective Esophageal Hypomotility
by: Sawangpong Jandee, et al.
Published: (2021) -
CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016)